A new study published in Nature has shed light on the epigenome of renal cell carcinomas (RCCs), the most common […]
A group of international researchers has performed the first prospective epigenome-wide analysis of DNA methylation in relation to incident CHD […]
Multi-omics involves bringing the multiple “omics” together, to get a clearer and more comprehensive picture of biological processes, disease pathology, […]
A multi-omics approach involves the combining of different “omics”: genomics, epigenomics, transcriptomics, and proteomics. The simultaneous study of each “omic” […]
Multi-omics is the combining of different “omics” – the genome, epigenome, transcriptome and proteome. Studying each layer in isolation can […]
In a recent study published in Science, researchers used genome-wide analysis of cell-free DNA (cfDNA) fragment end positions and surrounding […]
p53 has long been called the “guardian of the genome,” but how is this tumour suppressor protein maintaining genomic stability […]
New research, led by scientists at The Institute of Cancer Research, the Human Technopole in Milan, and Queen Mary University […]
Researchers at Mount Sinai’s Tisch Cancer Institute have demonstrated the first evidence linking the tumour microenvironment to a “super enhancer” […]
Andy Sharrocks (Professor at The University of Manchester) joins us to discuss the epigenetics of esophageal adenocarcinoma, why studying epigenetics […]
